前收市價 | 444.35 |
開市 | 440.00 |
買盤 | 0.00 x 0 |
賣出價 | 0.00 x 0 |
今日波幅 | 437.00 - 453.90 |
52 週波幅 | 370.55 - 545.90 |
成交量 | |
平均成交量 | 7,327,706 |
市值 | 2.363T |
Beta 值 (5 年,每月) | 0.70 |
市盈率 (最近 12 個月) | 21.14 |
每股盈利 (最近 12 個月) | 21.42 |
業績公佈日 | 2024年7月11日 - 2024年7月15日 |
遠期股息及收益率 | 1.00 (0.23%) |
除息日 | 2024年1月24日 |
1 年預測目標價 | 460.13 |
India's Wipro edged past low revenue expectations in the fourth quarter on Friday, helped by a pick up in its consulting business, and its new CEO said kickstarting growth in the country's No.4 software-services exporter was a top priority. "The numbers are largely in line with expectations as it was already low," said Centrum Broking analyst Piyush Pandey. Less than two weeks back, Wipro appointed company veteran Srinivas Pallia as its chief executive following the abrupt departure of Thierry Delaporte, whose term was filled with a string of top-level exits and a dearth of big deal wins.
Wipro GE Healthcare, a joint venture of India's Wipro Enterprises and a wholly owned entity of U.S.-based GE Healthcare, said it would invest 80 billion rupees ($960 million) in the country in its manufacturing and research and development facilities. Bengaluru-based medical technology company Wipro GE Healthcare said on Tuesday the investment would be done over the next five years to boost local manufacturing as it focuses on growing its footprint in the country in line with the government's "Make in India" initiative.
Nutanix (NTNX) expands its partnership with Wipro to introduce a new business unit focused on NTNX's technologies.